Drug Trial Radar · NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
2,115
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Oct 2029
Study completion Nov 2029
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatide, eloralintide and placebo for body weight reduction in participants with obesity. Participation in the study will last about 2 years.
Conditions
- Obesity
Interventions
eloralintide and tirzepatideDrug
Administered SC
EloralintideDrug
Administered SC
TirzepatideDrug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, Week 100
Locations
161 sites in 9 countries. Site status is shown where the registry gives one.
Care Access - 801 South Power Road, Mesa
Mesa, Arizona
Headlands Research - Scottsdale
Scottsdale, Arizona
Tucson Clinical Research Institute
Tucson, Arizona
Valley Clinical Trials, Inc.
Covina, California
Los Angeles Institute for Metabolic Research
Los Angeles, California
Peninsula Research Associates
Rolling Hills Estates, California
Artemis Institute for Clinical Research
San Diego, California
Southern California Clinical Research
Santa Ana, California
Yale University School of Medicine
New Haven, Connecticut
JEM Research Institute
Atlantis, Florida
K2 Medical Research - Maitland
Maitland, Florida
Flourish Research - Miami, LLC
Miami, Florida
Care Access - Tamarac
Tamarac, Florida
Care Access - Tampa
Tampa, Florida
Care Access - Dalton Walmart
Dalton, Georgia
Teak Research Consults - Dunwoody
Dunwoody, Georgia
Clinical Research Atlanta
Stockbridge, Georgia
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
IMA Clinical Research Chicago
Chicago, Illinois
DM Clinical Research - Indianapolis
Indianapolis, Indiana
Care Access - Eunice
Eunice, Louisiana
Clinical Trials Management, LLC d/b/a Flourish Research
Metairie, Louisiana
Pharmasite Research, Inc.
Baltimore, Maryland
Care Access - Baltimore
Baltimore, Maryland
Brigham and Women's Hospital Diabetes Program
Boston, Massachusetts
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi
IMA Clinical Research Las Vegas
Las Vegas, Nevada
Palm Research Center Sunset
Las Vegas, Nevada
IMA Clinical Research Albuquerque
Albuquerque, New Mexico
NYC Research INC
Long Island City, New York
Weill Cornell Medical College
New York, New York
IMA Clinical Research NYC Midtown
New York, New York
University of North Carolina Medical Center
Chapel Hill, North Carolina
Medication Management
Greensboro, North Carolina
Care Access - Raleigh
Raleigh, North Carolina
Clinical Research of Philadelphia
Philadelphia, Pennsylvania
Keystone Clinical Studies
Plymouth Meeting, Pennsylvania
Clinical Neuroscience Solutions Inc.
Memphis, Tennessee
JCCT - Juno Bellaire Site
Bellaire, Texas
Showing 40 of 161 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.